enlarged pore, laxity enlarged pore, laxity, monopolar radiofrequency
Conditions
Interventions
Eligible participants with enlarged pores and facial skin laxity were enrolled and treated with monopolar radiofrequency 300 shots on cheeks in the 1st session. Then after 1st session 1 month parti
Experimental Device
Sponsors
Faculty of Medicine Siriraj hospital
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Thai male or female, age 30-60 years old 2. Have visible enlarged pore assessed by dermatologist 3. Have mild-moderate skin laxity assessed by dermatologist
Exclusion criteria
Exclusion criteria: 1. Pregnant, postpartum participants within 1 year, and breastfeeding participants. 2. Participants who have not signed a consent form to voluntarily participate in the research study. 3. Participants who have undergone thread lifting, facial tightening procedures using devices, or facial surgery within 12 months prior to participating in the study. 4. Participants with a history of receiving dermal fillers, botulinum toxin, or collagen-stimulating substances within 6 months prior to participating in the study. 5. Participants with a history of Cushing's syndrome or Ehlers-Danlos syndrome. 6. Participants currently taking oral Isotretinoin. 7. Participants diagnosed with cancer, undergoing cancer treatment, or having skin cancer in the treatment area. 8. Participants with severe chronic diseases, those with a pacemaker, or those with metal implants in the facial area. 9. Participants with a history of immunodeficiency, including those infected with HIV or diagnosed with AIDS. 10. Participants with a history of keloid scars or skin rashes in the treatment area. 11. Participants with wounds or skin infections in the treatment area. 12. Participants with a history of herpes or active herpes infection. 13. Participants with a history of psychiatric disorders. 14. Participants with conditions deemed unsafe for participation by the investigators. 15. Participants who do not consent to having their photographs taken for treatment evaluation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean pore volume, mean pore area, pore count, pore density Baseline, 1 month after 1st treatment, 1 month after 2nd treatment, 3 months after 2nd treatment and 6 months after 2nd treatment Antera 3D,sebum level Baseline, 1 month after 1st treatment, 1 month after 2nd treatment, 3 months after 2nd treatment and 6 months after 2nd treatment sebumeter,Safety Baseline, 1 month after 1st treatment, 1 month after 2nd treatment, 3 months after 2nd treatment and 6 months after 2nd treatment Adverse event | — |
Secondary
| Measure | Time frame |
|---|---|
| Volume change Baseline, 1 month after 1st treatment, 1 month after 2nd treatment, 3 months after 2nd treatment and 6 months after 2nd treatment vectra ,lifting effect and volume change Baseline, 1 month after 1st treatment, 1 month after 2nd treatment, 3 months after 2nd treatment and 6 months after 2nd treatment Quantificare,percent improvement Baseline, 1 month after 1st treatment, 1 month after 2nd treatment, 3 months after 2nd treatment and 6 months after 2nd treatment Patient improvement scale | — |
Countries
Thailand
Contacts
Public ContactRungsima Wanitphakdeedecha
Faculty of Medicine Siriraj Hospital, Mahidol University
Outcome results
None listed